How many institutions held MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value in Q4 2022?

6 institutional investors reported MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value for Q4 2022. Use the holders table for investor-level position and value details.

MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA)

Q: What does CUSIP 552641102 represent in this 13F holders report?

CUSIP 552641102 is the security identifier for MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 552641102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 39,817,308
Total 13F shares: 297,126
Share change: +65,849
Total reported value: $1,043,412
Price per share: $3.51
Number of holders: 6
Value change: +$236,126
Number of buys: 5
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 552641102?
CUSIP 552641102 identifies MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 552641102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MAIA - MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Lynwood Capital Management Inc.	13F	Company	0.5%	199,785	$659,000	—	30 Sep 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.03%	11,811	$39,000	—	30 Sep 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.03%	10,210	$34,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	0.01%	4,588	$15,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	0.01%	3,572	$12,000	—	30 Sep 2022	13F
OPTIMUM INVESTMENT ADVISORS	13F	Company	0%	1,000	$3,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	311	$1,000	—	30 Sep 2022	13F
Laurentiu Vlad	3/4/5	Director	— class O/S missing	3,045	—	—	30 Dec 2022	3/4/5

Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) as of Q4 2022

As of 31 Dec 2022, MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 297,126 shares. The largest 6 holders included Lynwood Capital Management Inc., Centric Wealth Management, BlackRock Inc., UBS Group AG, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

-1

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.